The global Pharmaceutical Analysis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

From a downstream perspective, CRO accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Pharmaceutical Analysis Services leading manufacturers including Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, etc., dominate supply; the top five capture approximately % of global revenue, with Eurofins leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Analysis Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Pharmaceutical Analysis Services Market Report

Report Metric	Details
Report Name	Pharmaceutical Analysis Services Market
Segment by Type	Raw Material Analysis Microbiological Analysis Drug Packaging Material Analysis Biological Analysis and Testing Other
Segment by Application	CRO CMO and CDMO Finished Drugs and Environment
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical, DYNALABS, ADPEN Laboratories, ARL Bio Pharma, West Pharmaceutical, Microbac, Element (Analytical Lab Group), Piramal Pharma Solutions, CTI, Weipu, PONY Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Pharmaceutical Analysis Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmaceutical Analysis Services Market report?

Ans: The main players in the Pharmaceutical Analysis Services Market are Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical, DYNALABS, ADPEN Laboratories, ARL Bio Pharma, West Pharmaceutical, Microbac, Element (Analytical Lab Group), Piramal Pharma Solutions, CTI, Weipu, PONY Medicine

What are the Application segmentation covered in the Pharmaceutical Analysis Services Market report?

Ans: The Applications covered in the Pharmaceutical Analysis Services Market report are CRO, CMO and CDMO, Finished Drugs and Environment

What are the Type segmentation covered in the Pharmaceutical Analysis Services Market report?

Ans: The Types covered in the Pharmaceutical Analysis Services Market report are Raw Material Analysis, Microbiological Analysis, Drug Packaging Material Analysis, Biological Analysis and Testing, Other

1 Study Coverage

1.1 Introduction to Pharmaceutical Analysis Services: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Pharmaceutical Analysis Services Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Raw Material Analysis

1.2.3 Microbiological Analysis

1.2.4 Drug Packaging Material Analysis

1.2.5 Biological Analysis and Testing

1.2.6 Other

1.3 Market Segmentation by Application

1.3.1 Global Pharmaceutical Analysis Services Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 CRO

1.3.3 CMO and CDMO

1.3.4 Finished Drugs and Environment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pharmaceutical Analysis Services Revenue Estimates and Forecasts 2020-2031

2.2 Global Pharmaceutical Analysis Services Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Pharmaceutical Analysis Services Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Pharmaceutical Analysis Services Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Raw Material Analysis Market Size by Players

3.3.2 Microbiological Analysis Market Size by Players

3.3.3 Drug Packaging Material Analysis Market Size by Players

3.3.4 Biological Analysis and Testing Market Size by Players

3.3.5 Other Market Size by Players

3.4 Global Pharmaceutical Analysis Services Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Pharmaceutical Analysis Services Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Pharmaceutical Analysis Services Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Pharmaceutical Analysis Services Market Size by Type (2020-2031)

6.4 North America Pharmaceutical Analysis Services Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Pharmaceutical Analysis Services Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Pharmaceutical Analysis Services Market Size by Type (2020-2031)

7.4 Europe Pharmaceutical Analysis Services Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Pharmaceutical Analysis Services Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Pharmaceutical Analysis Services Market Size by Type (2020-2031)

8.4 Asia-Pacific Pharmaceutical Analysis Services Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Pharmaceutical Analysis Services Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Pharmaceutical Analysis Services Market Size by Type (2020-2031)

9.4 Central and South America Pharmaceutical Analysis Services Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Pharmaceutical Analysis Services Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Pharmaceutical Analysis Services Market Size by Type (2020-2031)

10.4 Middle East and Africa Pharmaceutical Analysis Services Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Pharmaceutical Analysis Services Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Eurofins

11.1.1 Eurofins Corporation Information

11.1.2 Eurofins Business Overview

11.1.3 Eurofins Pharmaceutical Analysis Services Product Features and Attributes

11.1.4 Eurofins Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.1.5 Eurofins Pharmaceutical Analysis Services Revenue by Product in 2024

11.1.6 Eurofins Pharmaceutical Analysis Services Revenue by Application in 2024

11.1.7 Eurofins Pharmaceutical Analysis Services Revenue by Geographic Area in 2024

11.1.8 Eurofins Pharmaceutical Analysis Services SWOT Analysis

11.1.9 Eurofins Recent Developments

11.2 WuXi AppTec

11.2.1 WuXi AppTec Corporation Information

11.2.2 WuXi AppTec Business Overview

11.2.3 WuXi AppTec Pharmaceutical Analysis Services Product Features and Attributes

11.2.4 WuXi AppTec Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.2.5 WuXi AppTec Pharmaceutical Analysis Services Revenue by Product in 2024

11.2.6 WuXi AppTec Pharmaceutical Analysis Services Revenue by Application in 2024

11.2.7 WuXi AppTec Pharmaceutical Analysis Services Revenue by Geographic Area in 2024

11.2.8 WuXi AppTec Pharmaceutical Analysis Services SWOT Analysis

11.2.9 WuXi AppTec Recent Developments

11.3 Pace Analytical Services

11.3.1 Pace Analytical Services Corporation Information

11.3.2 Pace Analytical Services Business Overview

11.3.3 Pace Analytical Services Pharmaceutical Analysis Services Product Features and Attributes

11.3.4 Pace Analytical Services Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.3.5 Pace Analytical Services Pharmaceutical Analysis Services Revenue by Product in 2024

11.3.6 Pace Analytical Services Pharmaceutical Analysis Services Revenue by Application in 2024

11.3.7 Pace Analytical Services Pharmaceutical Analysis Services Revenue by Geographic Area in 2024

11.3.8 Pace Analytical Services Pharmaceutical Analysis Services SWOT Analysis

11.3.9 Pace Analytical Services Recent Developments

11.4 Catalent

11.4.1 Catalent Corporation Information

11.4.2 Catalent Business Overview

11.4.3 Catalent Pharmaceutical Analysis Services Product Features and Attributes

11.4.4 Catalent Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.4.5 Catalent Pharmaceutical Analysis Services Revenue by Product in 2024

11.4.6 Catalent Pharmaceutical Analysis Services Revenue by Application in 2024

11.4.7 Catalent Pharmaceutical Analysis Services Revenue by Geographic Area in 2024

11.4.8 Catalent Pharmaceutical Analysis Services SWOT Analysis

11.4.9 Catalent Recent Developments

11.5 LabCorp (Covance)

11.5.1 LabCorp (Covance) Corporation Information

11.5.2 LabCorp (Covance) Business Overview

11.5.3 LabCorp (Covance) Pharmaceutical Analysis Services Product Features and Attributes

11.5.4 LabCorp (Covance) Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.5.5 LabCorp (Covance) Pharmaceutical Analysis Services Revenue by Product in 2024

11.5.6 LabCorp (Covance) Pharmaceutical Analysis Services Revenue by Application in 2024

11.5.7 LabCorp (Covance) Pharmaceutical Analysis Services Revenue by Geographic Area in 2024

11.5.8 LabCorp (Covance) Pharmaceutical Analysis Services SWOT Analysis

11.5.9 LabCorp (Covance) Recent Developments

11.6 PPD

11.6.1 PPD Corporation Information

11.6.2 PPD Business Overview

11.6.3 PPD Pharmaceutical Analysis Services Product Features and Attributes

11.6.4 PPD Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.6.5 PPD Recent Developments

11.7 Element (Exova)

11.7.1 Element (Exova) Corporation Information

11.7.2 Element (Exova) Business Overview

11.7.3 Element (Exova) Pharmaceutical Analysis Services Product Features and Attributes

11.7.4 Element (Exova) Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.7.5 Element (Exova) Recent Developments

11.8 ALS Pharmaceutical

11.8.1 ALS Pharmaceutical Corporation Information

11.8.2 ALS Pharmaceutical Business Overview

11.8.3 ALS Pharmaceutical Pharmaceutical Analysis Services Product Features and Attributes

11.8.4 ALS Pharmaceutical Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.8.5 ALS Pharmaceutical Recent Developments

11.9 Intertek Group

11.9.1 Intertek Group Corporation Information

11.9.2 Intertek Group Business Overview

11.9.3 Intertek Group Pharmaceutical Analysis Services Product Features and Attributes

11.9.4 Intertek Group Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.9.5 Intertek Group Recent Developments

11.10 SGS

11.10.1 SGS Corporation Information

11.10.2 SGS Business Overview

11.10.3 SGS Pharmaceutical Analysis Services Product Features and Attributes

11.10.4 SGS Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Boston Analytical

11.11.1 Boston Analytical Corporation Information

11.11.2 Boston Analytical Business Overview

11.11.3 Boston Analytical Pharmaceutical Analysis Services Product Features and Attributes

11.11.4 Boston Analytical Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.11.5 Boston Analytical Recent Developments

11.12 DYNALABS

11.12.1 DYNALABS Corporation Information

11.12.2 DYNALABS Business Overview

11.12.3 DYNALABS Pharmaceutical Analysis Services Product Features and Attributes

11.12.4 DYNALABS Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.12.5 DYNALABS Recent Developments

11.13 ADPEN Laboratories

11.13.1 ADPEN Laboratories Corporation Information

11.13.2 ADPEN Laboratories Business Overview

11.13.3 ADPEN Laboratories Pharmaceutical Analysis Services Product Features and Attributes

11.13.4 ADPEN Laboratories Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.13.5 ADPEN Laboratories Recent Developments

11.14 ARL Bio Pharma

11.14.1 ARL Bio Pharma Corporation Information

11.14.2 ARL Bio Pharma Business Overview

11.14.3 ARL Bio Pharma Pharmaceutical Analysis Services Product Features and Attributes

11.14.4 ARL Bio Pharma Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.14.5 ARL Bio Pharma Recent Developments

11.15 West Pharmaceutical

11.15.1 West Pharmaceutical Corporation Information

11.15.2 West Pharmaceutical Business Overview

11.15.3 West Pharmaceutical Pharmaceutical Analysis Services Product Features and Attributes

11.15.4 West Pharmaceutical Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.15.5 West Pharmaceutical Recent Developments

11.16 Microbac

11.16.1 Microbac Corporation Information

11.16.2 Microbac Business Overview

11.16.3 Microbac Pharmaceutical Analysis Services Product Features and Attributes

11.16.4 Microbac Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.16.5 Microbac Recent Developments

11.17 Element (Analytical Lab Group)

11.17.1 Element (Analytical Lab Group) Corporation Information

11.17.2 Element (Analytical Lab Group) Business Overview

11.17.3 Element (Analytical Lab Group) Pharmaceutical Analysis Services Product Features and Attributes

11.17.4 Element (Analytical Lab Group) Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.17.5 Element (Analytical Lab Group) Recent Developments

11.18 Piramal Pharma Solutions

11.18.1 Piramal Pharma Solutions Corporation Information

11.18.2 Piramal Pharma Solutions Business Overview

11.18.3 Piramal Pharma Solutions Pharmaceutical Analysis Services Product Features and Attributes

11.18.4 Piramal Pharma Solutions Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.18.5 Piramal Pharma Solutions Recent Developments

11.19 CTI

11.19.1 CTI Corporation Information

11.19.2 CTI Business Overview

11.19.3 CTI Pharmaceutical Analysis Services Product Features and Attributes

11.19.4 CTI Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.19.5 CTI Recent Developments

11.20 Weipu

11.20.1 Weipu Corporation Information

11.20.2 Weipu Business Overview

11.20.3 Weipu Pharmaceutical Analysis Services Product Features and Attributes

11.20.4 Weipu Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.20.5 Weipu Recent Developments

11.21 PONY Medicine

11.21.1 PONY Medicine Corporation Information

11.21.2 PONY Medicine Business Overview

11.21.3 PONY Medicine Pharmaceutical Analysis Services Product Features and Attributes

11.21.4 PONY Medicine Pharmaceutical Analysis Services Revenue and Gross Margin (2020-2025)

11.21.5 PONY Medicine Recent Developments

12 Pharmaceutical Analysis ServicesIndustry Chain Analysis

12.1 Pharmaceutical Analysis Services Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Pharmaceutical Analysis Services Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Pharmaceutical Analysis Services Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Element (Analytical Lab Group)

Piramal Pharma Solutions

CTI

Weipu

PONY Medicine

List of Tables

Table 1. Global Pharmaceutical Analysis Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Pharmaceutical Analysis Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Pharmaceutical Analysis Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Pharmaceutical Analysis Services Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Pharmaceutical Analysis Services Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Pharmaceutical Analysis Services Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Pharmaceutical Analysis Services Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Pharmaceutical Analysis Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Analysis Services as of 2024)

Table 11. Global Pharmaceutical Analysis Services Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Pharmaceutical Analysis Services Companies Headquarters

Table 13. Global Pharmaceutical Analysis Services Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Pharmaceutical Analysis Services Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Pharmaceutical Analysis Services Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Pharmaceutical Analysis Services Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Pharmaceutical Analysis Services Revenue by Application (2026-2031) & (US$ Million)

Table 21. Pharmaceutical Analysis Services High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Pharmaceutical Analysis Services Growth Accelerators and Market Barriers

Table 25. North America Pharmaceutical Analysis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Pharmaceutical Analysis Services Growth Accelerators and Market Barriers

Table 27. Europe Pharmaceutical Analysis Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Pharmaceutical Analysis Services Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Pharmaceutical Analysis Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Pharmaceutical Analysis Services Investment Opportunities and Key Challenges

Table 31. Central and South America Pharmaceutical Analysis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Pharmaceutical Analysis Services Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Pharmaceutical Analysis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Eurofins Corporation Information

Table 35. Eurofins Description and Major Businesses

Table 36. Eurofins Product Features and Attributes

Table 37. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Eurofins Revenue Proportion by Product in 2024

Table 39. Eurofins Revenue Proportion by Application in 2024

Table 40. Eurofins Revenue Proportion by Geographic Area in 2024

Table 41. Eurofins Pharmaceutical Analysis Services SWOT Analysis

Table 42. Eurofins Recent Developments

Table 43. WuXi AppTec Corporation Information

Table 44. WuXi AppTec Description and Major Businesses

Table 45. WuXi AppTec Product Features and Attributes

Table 46. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. WuXi AppTec Revenue Proportion by Product in 2024

Table 48. WuXi AppTec Revenue Proportion by Application in 2024

Table 49. WuXi AppTec Revenue Proportion by Geographic Area in 2024

Table 50. WuXi AppTec Pharmaceutical Analysis Services SWOT Analysis

Table 51. WuXi AppTec Recent Developments

Table 52. Pace Analytical Services Corporation Information

Table 53. Pace Analytical Services Description and Major Businesses

Table 54. Pace Analytical Services Product Features and Attributes

Table 55. Pace Analytical Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Pace Analytical Services Revenue Proportion by Product in 2024

Table 57. Pace Analytical Services Revenue Proportion by Application in 2024

Table 58. Pace Analytical Services Revenue Proportion by Geographic Area in 2024

Table 59. Pace Analytical Services Pharmaceutical Analysis Services SWOT Analysis

Table 60. Pace Analytical Services Recent Developments

Table 61. Catalent Corporation Information

Table 62. Catalent Description and Major Businesses

Table 63. Catalent Product Features and Attributes

Table 64. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Catalent Revenue Proportion by Product in 2024

Table 66. Catalent Revenue Proportion by Application in 2024

Table 67. Catalent Revenue Proportion by Geographic Area in 2024

Table 68. Catalent Pharmaceutical Analysis Services SWOT Analysis

Table 69. Catalent Recent Developments

Table 70. LabCorp (Covance) Corporation Information

Table 71. LabCorp (Covance) Description and Major Businesses

Table 72. LabCorp (Covance) Product Features and Attributes

Table 73. LabCorp (Covance) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. LabCorp (Covance) Revenue Proportion by Product in 2024

Table 75. LabCorp (Covance) Revenue Proportion by Application in 2024

Table 76. LabCorp (Covance) Revenue Proportion by Geographic Area in 2024

Table 77. LabCorp (Covance) Pharmaceutical Analysis Services SWOT Analysis

Table 78. LabCorp (Covance) Recent Developments

Table 79. PPD Corporation Information

Table 80. PPD Description and Major Businesses

Table 81. PPD Product Features and Attributes

Table 82. PPD Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. PPD Recent Developments

Table 84. Element (Exova) Corporation Information

Table 85. Element (Exova) Description and Major Businesses

Table 86. Element (Exova) Product Features and Attributes

Table 87. Element (Exova) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Element (Exova) Recent Developments

Table 89. ALS Pharmaceutical Corporation Information

Table 90. ALS Pharmaceutical Description and Major Businesses

Table 91. ALS Pharmaceutical Product Features and Attributes

Table 92. ALS Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. ALS Pharmaceutical Recent Developments

Table 94. Intertek Group Corporation Information

Table 95. Intertek Group Description and Major Businesses

Table 96. Intertek Group Product Features and Attributes

Table 97. Intertek Group Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Intertek Group Recent Developments

Table 99. SGS Corporation Information

Table 100. SGS Description and Major Businesses

Table 101. SGS Product Features and Attributes

Table 102. SGS Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. SGS Recent Developments

Table 104. Boston Analytical Corporation Information

Table 105. Boston Analytical Description and Major Businesses

Table 106. Boston Analytical Product Features and Attributes

Table 107. Boston Analytical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. Boston Analytical Recent Developments

Table 109. DYNALABS Corporation Information

Table 110. DYNALABS Description and Major Businesses

Table 111. DYNALABS Product Features and Attributes

Table 112. DYNALABS Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. DYNALABS Recent Developments

Table 114. ADPEN Laboratories Corporation Information

Table 115. ADPEN Laboratories Description and Major Businesses

Table 116. ADPEN Laboratories Product Features and Attributes

Table 117. ADPEN Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. ADPEN Laboratories Recent Developments

Table 119. ARL Bio Pharma Corporation Information

Table 120. ARL Bio Pharma Description and Major Businesses

Table 121. ARL Bio Pharma Product Features and Attributes

Table 122. ARL Bio Pharma Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. ARL Bio Pharma Recent Developments

Table 124. West Pharmaceutical Corporation Information

Table 125. West Pharmaceutical Description and Major Businesses

Table 126. West Pharmaceutical Product Features and Attributes

Table 127. West Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. West Pharmaceutical Recent Developments

Table 129. Microbac Corporation Information

Table 130. Microbac Description and Major Businesses

Table 131. Microbac Product Features and Attributes

Table 132. Microbac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. Microbac Recent Developments

Table 134. Element (Analytical Lab Group) Corporation Information

Table 135. Element (Analytical Lab Group) Description and Major Businesses

Table 136. Element (Analytical Lab Group) Product Features and Attributes

Table 137. Element (Analytical Lab Group) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 138. Element (Analytical Lab Group) Recent Developments

Table 139. Piramal Pharma Solutions Corporation Information

Table 140. Piramal Pharma Solutions Description and Major Businesses

Table 141. Piramal Pharma Solutions Product Features and Attributes

Table 142. Piramal Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)

Table 143. Piramal Pharma Solutions Recent Developments

Table 144. CTI Corporation Information

Table 145. CTI Description and Major Businesses

Table 146. CTI Product Features and Attributes

Table 147. CTI Revenue (US$ Million) and Gross Margin (2020-2025)

Table 148. CTI Recent Developments

Table 149. Weipu Corporation Information

Table 150. Weipu Description and Major Businesses

Table 151. Weipu Product Features and Attributes

Table 152. Weipu Revenue (US$ Million) and Gross Margin (2020-2025)

Table 153. Weipu Recent Developments

Table 154. PONY Medicine Corporation Information

Table 155. PONY Medicine Description and Major Businesses

Table 156. PONY Medicine Product Features and Attributes

Table 157. PONY Medicine Revenue (US$ Million) and Gross Margin (2020-2025)

Table 158. PONY Medicine Recent Developments

Table 159. Raw Materials Key Suppliers

Table 160. Distributors List

Table 161. Market Trends and Market Evolution

Table 162. Market Drivers and Opportunities

Table 163. Market Challenges, Risks, and Restraints

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceutical Analysis Services Product Picture

Figure 2. Global Pharmaceutical Analysis Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Raw Material Analysis Product Picture

Figure 4. Microbiological Analysis Product Picture

Figure 5. Drug Packaging Material Analysis Product Picture

Figure 6. Biological Analysis and Testing Product Picture

Figure 7. Other Product Picture

Figure 8. Global Pharmaceutical Analysis Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. CRO

Figure 10. CMO and CDMO

Figure 11. Finished Drugs and Environment

Figure 12. Pharmaceutical Analysis Services Report Years Considered

Figure 13. Global Pharmaceutical Analysis Services Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 15. Global Pharmaceutical Analysis Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Pharmaceutical Analysis Services Revenue Market Share by Region (2020-2031)

Figure 17. Global Pharmaceutical Analysis Services Revenue Market Share Ranking (2024)

Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 19. Raw Material Analysis Revenue Market Share by Player in 2024

Figure 20. Microbiological Analysis Revenue Market Share by Player in 2024

Figure 21. Drug Packaging Material Analysis Revenue Market Share by Player in 2024

Figure 22. Biological Analysis and Testing Revenue Market Share by Player in 2024

Figure 23. Other Revenue Market Share by Player in 2024

Figure 24. Global Pharmaceutical Analysis Services Revenue Market Share by Type (2020-2031)

Figure 25. Global Pharmaceutical Analysis Services Revenue Market Share by Application (2020-2031)

Figure 26. North America Pharmaceutical Analysis Services Revenue YoY (2020-2031) & (US$ Million)

Figure 27. North America Top 5 Players Pharmaceutical Analysis Services Revenue (US$ Million) in 2024

Figure 28. North America Pharmaceutical Analysis Services Revenue (US$ Million) by Type (2020 - 2031)

Figure 29. North America Pharmaceutical Analysis Services Revenue (US$ Million) by Application (2020-2031)

Figure 30. US Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 31. Canada Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 32. Mexico Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 33. Europe Pharmaceutical Analysis Services Revenue YoY (2020-2031) & (US$ Million)

Figure 34. Europe Top 5 Players Pharmaceutical Analysis Services Revenue (US$ Million) in 2024

Figure 35. Europe Pharmaceutical Analysis Services Revenue (US$ Million) by Type (2020-2031)

Figure 36. Europe Pharmaceutical Analysis Services Revenue (US$ Million) by Application (2020-2031)

Figure 37. Germany Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 38. France Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 39. U.K. Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 40. Italy Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 41. Russia Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Pharmaceutical Analysis Services Revenue YoY (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Top 8 Players Pharmaceutical Analysis Services Revenue (US$ Million) in 2024

Figure 44. Asia-Pacific Pharmaceutical Analysis Services Revenue (US$ Million) by Type (2020-2031)

Figure 45. Asia-Pacific Pharmaceutical Analysis Services Revenue (US$ Million) by Application (2020-2031)

Figure 46. Indonesia Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 47. Japan Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 48. South Korea Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 49. Australia Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 50. India Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 51. Indonesia Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 52. Vietnam Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 53. Malaysia Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 54. Philippines Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 55. Singapore Pharmaceutical Analysis Services Revenue (2020-2031) & (US$ Million)

Figure 56. Central and South America Pharmaceutical Analysis Services Revenue YoY (2020-2031) & (US$ Million)

Figure 57. Central and South America Top 5 Players Pharmaceutical Analysis Services Revenue (US$ Million) in 2024

Figure 58. Central and South America Pharmaceutical Analysis Services Revenue (US$ Million) by Type (2020-2031)

Figure 59. Central and South America Pharmaceutical Analysis Services Revenue (US$ Million) by Application (2020-2031)

Figure 60. Brazil Pharmaceutical Analysis Services Revenue (2020-2025) & (US$ Million)

Figure 61. Argentina Pharmaceutical Analysis Services Revenue (2020-2025) & (US$ Million)

Figure 62. Middle East and Africa Pharmaceutical Analysis Services Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Middle East and Africa Top 5 Players Pharmaceutical Analysis Services Revenue (US$ Million) in 2024

Figure 64. South America Pharmaceutical Analysis Services Revenue (US$ Million) by Type (2020-2031)

Figure 65. Middle East and Africa Pharmaceutical Analysis Services Revenue (US$ Million) by Application (2020-2031)

Figure 66. GCC Countries Pharmaceutical Analysis Services Revenue (2020-2025) & (US$ Million)

Figure 67. Israel Pharmaceutical Analysis Services Revenue (2020-2025) & (US$ Million)

Figure 68. Egypt Pharmaceutical Analysis Services Revenue (2020-2025) & (US$ Million)

Figure 69. South Africa Pharmaceutical Analysis Services Revenue (2020-2025) & (US$ Million)

Figure 70. Pharmaceutical Analysis Services Industry Chain Mapping

Figure 71. Channels of Distribution (Direct Vs Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions